share_log

Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $71

Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $71

大摩資源lof維持對globus medical的等比重評級,將目標價提高至71美元。
Benzinga ·  07/15 13:02

Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Equal-Weight and raises the price target from $67 to $71.

大摩資源lof 分析師Drew Ranieri 維持對紐交所GMED股票的等比重評級,將目標價從67美元上調至71美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論